2016
DOI: 10.1371/journal.pone.0149550
|View full text |Cite
|
Sign up to set email alerts
|

Using Drugs to Probe the Variability of Trans-Epithelial Airway Resistance

Abstract: BackgroundPrecision medicine aims to combat the variability of the therapeutic response to a given medicine by delivering the right medicine to the right patient. However, the application of precision medicine is predicated on a prior quantitation of the variance of the reference range of normality. Airway pathophysiology provides a good example due to a very variable first line of defence against airborne assault. Humans differ in their susceptibility to inhaled pollutants and pathogens in part due to the mag… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

4
12
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 44 publications
4
12
0
Order By: Relevance
“…The results shown in Figure 2 and Supplemental Figure 3 also highlight the robustness of the measurement across multiple microscopes or imaging configurations. Errors between different microscope measurements of the same sample were within 4.4% of the signal as compared with an average error of 31% on reference standards for VEGF ELISAs (30) and 100% for TER measurements in epithelium (31). This represents 1 to 2 orders of magnitude reduction in variability for a potential release assay for a cell-therapy product or when used in a drug screening methodology.…”
Section: Discussionmentioning
confidence: 79%
See 1 more Smart Citation
“…The results shown in Figure 2 and Supplemental Figure 3 also highlight the robustness of the measurement across multiple microscopes or imaging configurations. Errors between different microscope measurements of the same sample were within 4.4% of the signal as compared with an average error of 31% on reference standards for VEGF ELISAs (30) and 100% for TER measurements in epithelium (31). This represents 1 to 2 orders of magnitude reduction in variability for a potential release assay for a cell-therapy product or when used in a drug screening methodology.…”
Section: Discussionmentioning
confidence: 79%
“…Additionally, the method worked on 2 different donors, not only as an end-point assay of tissue health, but also as a noninvasive tool for tracking tissue development during the long maturation period (approximately 35 days) (33). Importantly, the accuracy of the algorithms in predicting both TER and VEGFratio was close to the measurement uncertainty for both TER (31) and VEGF (30,34). The generalizability of such metrics across cell lines, regardless of donor, adds to the broad utility of this work, as here we show that even with a limited data set, strong predictive ability, regardless of donor and clone, was shown ( Figure 5).…”
Section: Discussionmentioning
confidence: 99%
“…BMI-1 TRANSDUCTION OF HBEC PROVIDES NOVEL RESPIRATORY MODELS epithelial Transwells in a 24-well ALI culture format per passage, enabling the generation of a minimum of~90 -100 Transwells from a single donor. This is significantly higher than the 10 -15 epithelial Transwells that can be generated with 1ϫ10 6 primary bronchial epithelial cells (typical quantity obtained from commercial providers) or brushing of the nasal turbinate of a single donor (29). Furthermore, subculturing of BMI-1 transformed cells, as opposed to seeding ALI cultures, would enable banking of early passage cells and the potential to generate exponentially more functional epithelia at each passage.…”
Section: L265mentioning
confidence: 99%
“…BMI-1 TRANSDUCTION OF HBEC PROVIDES NOVEL RESPIRATORY MODELS (29), who recently demonstrated baseline TEER values ranged from 309 to 2,963 ⍀•cm 2 in ALI cultures generated from the cells of 18 healthy donors.…”
Section: L264mentioning
confidence: 99%
See 1 more Smart Citation